Industry News
Scientific perspectives on the therapeutic components used at BioCells Medical — cellular therapy, immunomodulation, exosome biology, neurostimulation, and molecular medicine.
MSCs exert their therapeutic effect not by replacing damaged tissue, but through paracrine signalling — secreting anti-inflammatory cytokines, trophic factors, and extracellular vesicles that modulate the disease microenvironment.
In autoimmune neurological conditions, the immune system itself drives tissue destruction. T-regs address this through targeted suppression of pathological immune responses — without the broad immunosuppression that increases infection risk.
MSC-derived exosomes carry the therapeutic cargo of their parent cells — microRNA, proteins, and signalling molecules — but at nanoscale dimensions that allow them to cross the blood-brain barrier.
Cellular therapy provides the biological substrate for neural repair. Neurostimulation activates the circuits that must integrate that repair into functional improvement. The combination is synergistic.
Motor neurons under degenerative stress require enormous energy to function while their mitochondria are compromised. Peptide therapy targets this metabolic crisis directly — restoring cellular energy production where it matters most.
